Background: While current clinically administered anticoagulant medications have
demonstrated effectiveness, they have also precipitated significant risks: severe bleeding …

Background and aim Current observational studies have compared the effectiveness and
safety of edoxaban with other oral anticoagulants in patients with AF, but the results are still …

Excellent outcomes of angioplasty/stenting for the post-thrombotic syndrome (PTS) have
been reported, notably regarding objective criteria in the vast French SFICV cohort …

(1) Background: Little is known about how left ventricular systolic dysfunction (LVSD) affects
functional and clinical outcomes in acute ischemic stroke (AIS) patients undergoing …

Acute coronary syndrome (ACS) is a leading cause of mortality worldwide. Despite optimal
antiplatelet therapy recommendation after ischemic events, recurrent thrombotic …

A small natural substance called cirsilineol (CSL), which was discovered in the plant
Artemisia vestita, is lethal to many cancer cells and has antioxidant, anticancer, and …

Hyperacute synchronous cardiocerebral infarction (CCI) is an extremely rare condition with
an incidence of 0.009%. In the acute stage of ischemic stroke, there is a high prevalence of …

This study aims to investigate the association between HCT (Hematocrit) levels and adverse
outcomes in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA); …

Background: The percentage of elderly trauma patients under anticoagulation and
antiplatelet agents has been rising lately. With time, newer agents have been introduced …

BACKGROUND–Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia that
can lead to thromboembolic events, including cerebral vascular catastrophe and peripheral …